Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cook

Showing results (1021-1030 of 1,031) with videos related to

Pageof 104
Sort By:
Nature Communications|June 14, 2016
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosomeMitchell J Machiela, Weiyin Zhou, Eric Karlins, et al.
American Journal of Human Genetics|March 10, 2015
Characterization of large structural genetic mosaicism in human autosomesMitchell J Machiela, Weiyin Zhou, Joshua N Sampson, et al.
Cancer Discovery|July 20, 2016
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesSiddhartha P Kar, Jonathan Beesley, Ali Amin Al Olama, et al.
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Nature Communications|September 8, 2016
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locusKate Lawrenson, Siddhartha Kar, Karen McCue, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerCatherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Pageof 104

Showing results (1021-1030 of 1,031) with videos related to

Sort By:
Pageof 104
Nature Communications|June 14, 2016
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosomeMitchell J Machiela, Weiyin Zhou, Eric Karlins, et al.
American Journal of Human Genetics|March 10, 2015
Characterization of large structural genetic mosaicism in human autosomesMitchell J Machiela, Weiyin Zhou, Joshua N Sampson, et al.
Cancer Discovery|July 20, 2016
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer TypesSiddhartha P Kar, Jonathan Beesley, Ali Amin Al Olama, et al.
Journal of the National Cancer Institute|November 21, 2015
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian CancersHuong D Meeks, Honglin Song, Kyriaki Michailidou, et al.
Nature Genetics|January 13, 2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancerKaroline B Kuchenbaecker, Susan J Ramus, Jonathan Tyrer, et al.
Nature Communications|September 8, 2016
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locusKate Lawrenson, Siddhartha Kar, Karen McCue, et al.
European Journal of Human Genetics : EJHG|January 14, 2022
Polygenic risk modeling for prediction of epithelial ovarian cancer riskEileen O Dareng, Jonathan P Tyrer, Daniel R Barnes, et al.
Journal of Medical Genetics|September 7, 2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSMelissa C Southey, David E Goldgar, Robert Winqvist, et al.
Gynecologic Oncology|May 6, 2015
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer, Antoinette Hollestelle, Frederieke H van der Baan, et al.
Nature Genetics|March 28, 2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancerCatherine M Phelan, Karoline B Kuchenbaecker, Jonathan P Tyrer, et al.
Pageof 104